← Back to Clinical Trials
Recruiting NCT04720846

NCT04720846 Categorized PT for Non-arthritic Hip and Groin Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04720846
Status Recruiting
Phase
Sponsor Hospital for Special Surgery, New York
Condition Hip Pain
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2020-12-02
Primary Completion 2027-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Matrix-based physical therapyStandard-of-care physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2020-12-02 with a primary completion date of 2027-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is currently limited literature on a categorized physical therapy protocol for management of hip pain. Only a handful of studies have looked at the treatment of osteoarthritis of the hip with a standardized physical therapy treatment, primarily looking at manual therapy versus exercise therapy protocols. However, there are no studies observing the effect of a standardized physical therapy program on patients presenting with non-arthritic hip and groin pain. Based on the gap in the literature, this study will aim to assess the effect of matrix-based standard of care therapy in patients presenting with non-arthritic hip and groin pain.

Eligibility Criteria

Inclusion Criteria: * New patient presenting with non-arthritic hip impingement, hip pain, and groin pain (Tonnis 0-1) * 18-60 years old Exclusion Criteria: * Arthritic hip pain (Tonnis 2+) * \<18 and \>60 years old * History of spinal fusion surgery * History of low back pain with radicular pain * History of hip arthroscopy * History of inflammatory conditions, and other concurrent problems interfering with hip therapy (i.e., concurrent back/knee/foot/ankle/shoulder issues) * Patients currently taking TNF-alpha inhibitors for inflammatory conditions * History of prior knee osteotomy * Non-English speakers

Contact & Investigator

Central Contact

Jennifer Cheng

✉ chengj@hss.edu

📞 6467146870

Principal Investigator

Peter Moley, MD

PRINCIPAL INVESTIGATOR

Hospital for Special Surgery, New York

Frequently Asked Questions

Who can join the NCT04720846 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Hip Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04720846 currently recruiting?

Yes, NCT04720846 is actively recruiting participants. Contact the research team at chengj@hss.edu for enrollment information.

Where is the NCT04720846 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT04720846 clinical trial?

NCT04720846 is sponsored by Hospital for Special Surgery, New York. The principal investigator is Peter Moley, MD at Hospital for Special Surgery, New York. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology